Nucleus Software (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Nucleus Software Exports Limited |
|||
|
Price: ₹1,036.55 (-0.2%) | ||
| 52 Week Low: ₹999.00 52 Week High: ₹1,787.50 |
|||
| Market Capital: 3,000.55 Crore (Smallcap) | |||
| Technology -> Software - Application | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Nucleus Software Share Price Target For 2025
- 1.1.1: Nucleus Software Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Nucleus Software Share Price Target For 2026
- 1.2.1: Nucleus Software Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Nucleus Software Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Nucleus Software Brief Company Overview
- 4: Nucleus Software Financial Performance
- 4.0.1: Is Nucleus Software A Good Buy For Long Term?
Nucleus Software, a Small Cap company in the Software - Application Industry has delivered 261.0% returns in 5-year with 20.6% profit margin, making it a potential Multibagger.
To predict the Nucleus Software's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Nucleus Software Share Price Target For 2025
The line chart displays the monthly closing prices of Nucleus Software with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Nucleus Software shares in 2025, see the table below.
Nucleus Software Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1160.65 (+11.97%) | Price Action: 30 Oct 2024 Low |
| 2025 Target 2 | 1147.64 (+10.71%) | Price Action: 14 Mar 2024 Low |
| 2025 Target 1 | 1135.55 (+9.55%) | Price Action: 09 Dec 2024 Low |
| Current Price | 1036.55 | Nucleus Software's share price as of 21 Jan 2025 |
| Stop Loss 1 | 973.87 (-6.05%) | Price Action: Jun 2023 Low |
| Stop Loss 2 | 953.6 (-8.01%) | Price Action: Sep 2023 Low |
| Stop Loss 3 | 936.75 (-9.63%) | Price Action: Aug 2023 Low |
Short-Term Technical Outlook
Current Technical Position: Nucleus Software is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹1054.24 serves as the nearest technical reference point.
Historical Returns: 3-month: -13.03% | 6-month: -32.36% | 1-year: -34.56%
Nucleus Software Share Price Target For 2026
The line chart displays the monthly closing prices of Nucleus Software with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Nucleus Software shares in 2026, see the table below.
Nucleus Software Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1899.96 (+83.29%) | Price Action: Chart |
| 2026 Target 2 | 1864.53 (+79.87%) | Price Action: Chart |
| 2026 Target 1 | 1846.07 (+78.09%) | Fibonacci Extension Level 64.90% |
| Current Price | 1036.55 | Nucleus Software's share price as of 21 Jan 2025 |
| Stop Loss 1 | 839.41 (-19.02%) | Price Action: Chart |
| Stop Loss 2 | 831.02 (-19.82%) | Price Action: Chart |
| Stop Loss 3 | 816.06 (-21.28%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Nucleus Software is currently trading near its 52-week low of ₹999, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -34.56% | 3-year: +82.01% | 5-year: +261.04%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Nucleus Software Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,036.55 | ||
| 2025 | ₹1,495.63 | +44.28% | ₹1,518.06 |
| 2026 | ₹2,028.69 | +35.64% | ₹2,059.12 |
| 2027 | ₹2,822.49 | +39.12% | ₹2,864.83 |
| 2028 | ₹3,409.10 | +20.78% | ₹3,460.24 |
| 2029 | ₹4,281.02 | +25.57% | ₹4,345.24 |
| 2030 | ₹5,450.69 | +27.32% | ₹5,532.45 |
| 2031 | ₹6,644.64 | +21.9% | ₹6,744.31 |
| 2032 | ₹8,612.90 | +29.62% | ₹8,742.09 |
| 2033 | ₹10,630.21 | +23.42% | ₹10,789.66 |
| 2034 | ₹12,300.95 | +15.71% | ₹12,485.46 |
| 2035 | ₹14,868.43 | +20.87% | ₹15,091.46 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Nucleus Software Brief Company Overview
Nucleus Software Exports Limited Nucleus Software Exports Limited is a leading provider of mission-critical lending and transaction banking products to the financial services industry. Founded in 1986, the company has a strong presence in over 50 countries across the...
globe, including India, the Far East, South East Asia, Europe, the Middle East, Africa, Australia, and internationally. Key Products: FinnOne Neo (lending solution), FinnAxia (transaction banking solution), FarEdge Anomaly Detector (fraud detection solution) Services: Testing and consulting, application development and management, digital transformation, data management and analytics Nucleus is committed to providing innovative and reliable solutions that help financial institutions streamline their operations, reduce costs, and improve customer service.Nucleus Software Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 3,000.55 Crore | Market valuation of Nucleus Software's shares. |
| Revenue (TTM) | 815.03 Crore | Total revenue generated by Nucleus Software over the past twelve months. |
| Net Income (TTM) | +168.24 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.82% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +20.64% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-5.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-43.6% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.59 | Company's total debt divided by total shareholder equity. |
| Total Debt | 4.59 Crore | Sum of Nucleus Software's current & long-term financial obligations. |
| Total Cash | 400.99 Crore | Total amount of liquid funds available to Nucleus Software. |
| Beta | 0.33 | Beta is less than 1 indicating that the Nucleus Software's price is less volatile than the market. |
Is Nucleus Software A Good Buy For Long Term?
Nucleus Software, a small-cap stock with a market capitalization of ₹3,000.55 crore, presents a mixed picture for long-term investors. While its ₹168.24 crore net profit (20.64% margin) on ₹815.03 crore revenue (TTM) and substantial cash balance of ₹400.99 crore (Q2 2024-25) are positive, recent performance is concerning. The -43.6% YoY earnings drop and negative returns over the past year (-25.21%) warrant caution. Despite impressive 3- and 5-year returns (80.39% and 201.49% respectively), the current negative trend suggests it's currently an average buy, requiring close monitoring of future quarterly reports before considering a strong long-term investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
